Indications And Dose
Urinary frequency | Urinary urgency | Urinary incontinence ▶BY MOUTH ▶Adult: 5 mg once daily, increased if necessary to 10 mg once daily
PDF page 845
Drug reference
Urinary frequency | Urinary urgency | Urinary incontinence ▶BY MOUTH ▶Adult: 5 mg once daily, increased if necessary to 10 mg once daily
PDF page 845
DUE TO INTERACTIONS ▶Manufacturer advises max. dose 5 mg daily with concurrent use of potent inhibitors of CYP3A4; avoid concurrent use in patients who also have moderate hepatic impairment or severe renal impairment.
PDF page 845
Neurogenic bladder disorder. susceptibility to QT-interval prolongation
PDF page 845
The need for continuing therapy for urinary incontinence should be reviewed every 4–6 weeks until symptoms stabilise, and then every 6–12 months.
PDF page 845
→Appendix 1: solifenacin
PDF page 845
▶Common or very common Gastrointestinal discomfort ▶Uncommon Cystitis. dry eye. dry throat. fatigue. gastrointestinal disorders. nasal dryness. peripheral oedema. taste altered. urinary tract infection ▶Rare or very rare Hallucination ▶Frequency not known Anaphylactic reaction. appetite decreased. arrhythmias. delirium. dysphonia. glaucoma. hyperkalaemia. liver disorder. muscle weakness. QT interval prolongation. renal impairment
PDF page 845
Manufacturer advises caution—no information available.
PDF page 845
Manufacturer advises avoid—present in milk in animal studies.
PDF page 845
Manufacturer advises caution in moderate impairment (risk of increased half-life); avoid in severe impairment (no information available). Dose adjustments Manufacturer advises maximum 5 mg daily in moderate impairment.
PDF page 845
Dose adjustments Max. 5 mg daily if eGFR less than 30 mL/minute/1.73 m2.
PDF page 845
There can be variation in the licensing of different medicines containing the same drug. Forms available from special-order manufacturers include: oral suspension, oral solution Oral solution ▶Solifenacin succinate (Non-proprietary) Solifenacin succinate 1 mg per 1 ml Solifenacin 5mg/5ml oral solution sugar free sugar-free | 150 ml P £22.50 Oral suspension ▶Vesicare (Astellas Pharma Ltd) Solifenacin succinate 1 mg per 1 ml Vesicare 1mg/ml oral suspension sugar-free | 150 ml P £27.62 DT = £27.62 Genito-urinary system Tablet CAUTIONARY AND ADVISORY LABELS 3 ▶Solifenacin succinate (Non-proprietary) Solifenacin succinate 5 mg Solifenacin 5mg tablets | 30 tablet P £27.62 DT = £3.54 | 250 tablet P £29.50–£230.17 Solifenacin succinate 10 mg Solifenacin 10mg tablets | 30 tablet P £35.91 DT = £4.48 | 100 tablet P £119.70 | 250 tablet P £45.99–£299.25 ▶Vesicare (Astellas Pharma Ltd) Solifenacin succinate 5 mg Vesicare 5mg tablets | 30 tablet P £27.62 DT = £3.54 Solifenacin succinate 10 mg Vesicare 10mg tablets | 30 tablet P £35.91 DT = £4.48 eiiii F 820
PDF page 845
5 mg once daily, increased if necessary to 10 mg
First-line fragment. Read the complete Indications and Dose section above.
PDF page 845